Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

UCB Biopharma SRL

5 clinical trials · 5 recruiting · INDUSTRY

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by UCB Biopharma SRL

RECRUITINGPhase 3NCT06315322

A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence...

The purpose of the study is to investigate the long-term safety and tolerability of brivaracetam in study participants with childhood absence epilepsy or juvenile absence epilepsy.

Sponsor: UCB Biopharma SRLEnrolling: 12020 locations
Childhood Absence EpilepsyJuvenile Absence Epilepsy
RECRUITINGPhase 1NCT07290036

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in...

To demonstrate that bimekizumab administered intravenously is noninferior to subcutaneous administration.

Sponsor: UCB Biopharma SRLEnrolling: 39220 locations
Psoriatic ArthritisAxial Spondyloarthritis
RECRUITINGPhase 2 / Phase 3NCT06055959

A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

The purpose of this study is to assess the pharmacokinetics, pharmacodynamics, safety, tolerability, immunogenicity and activity of zilucoplan (ZLP) in pediatric study...

Sponsor: UCB Biopharma SRLEnrolling: 89 locations
Generalized Myasthenia Gravis
RECRUITINGPhase 2 / Phase 3NCT06149559

A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis

The purpose of the study is to assess the safety and tolerability of subcutaneous (sc) administration of rozanolixizumab in pediatric participants aged ≥2 to \<18 years with...

Sponsor: UCB Biopharma SRLEnrolling: 1213 locations
Generalized Myasthenia Gravis
RECRUITINGPhase 4NCT07246564

Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized...

The purpose of the study is to assess the clinical efficacy of rozanolixizumab in adult Chinese participants with generalized myasthenia gravis (gMG) in the first Treatment Cycle.

Sponsor: UCB Biopharma SRLEnrolling: 4011 locations
Myasthenia Gravis